Back to News
Oct 21, 2025 8:10 AM

NIH Grant Awarded to Further Research of Novel Chemical Pathway to Reverse MCI

SAN FRANCISCO, Oct. 21, 2025 (GLOBE NEWSWIRE) -- The NIH has awarded a new grant to Posit Science, the maker of the online BrainHQ brain exercises, to advance research, which showed in a neuro-imaging study published last week, that their brain exercises can significantly upregulate the production of a key brain chemical (acetylcholine), known to downregulate with normal cognitive aging and to decline more severely with pre-dementia and dementia. The new grant will help fund a study among people with the pre-dementia condition mild cognitive impairment (MCI) to see if their acetylcholine will be upregulated and their cognitive performance will improve.

MCI is a medical designation for cognitive impairment that exceeds normal age-related loss but does not yet meet the criteria for a dementia diagnosis. The Alzheimer's Association estimates that 12% to 18% of people over age 60 have MCI, and that 10 to 15% of people living with MCI develop dementia each year. The percentage converting to dementia increases with age, but most do not progress to a dementia diagnosis. There is no generally accepted successful treatment for MCI, though some interventions have shown positive results in studies.

The most prescribed medications for Alzheimer's disease are cholinesterase inhibitors (such as Aricept®), which ...